In this digital era, Vamsi Upputuri, a leading expert in regulatory automation, explores cutting-edge advancements in ...

Clinical trial complexity has significantly increased in the past decade. How can the industry adapt and innovate to remain ...

Machine learning can help investors dive deeper into trial data to evaluate the true potential of an asset and uncover new ...

Elisa Cascade, CPO at Advarra explains why addressing the challenges faced by clinical research sites is vital for improving patient trust and the overall viability of clinical trials.

Rezolute , Inc. (NASDAQ:RZLT), a clinical-stage biopharmaceutical company, is making significant strides in the development of its lead drug candidate, ersodetug, for the treatment of congenital ...

Researchers have suggested that uniform evidence standards and reporting requirements could help speed patient access to cell ...

Drug development is an expensive and high-risk process. The median cost per approved drug can reach up to $2.8 billion, ...

While laying out her options to fight the cancer, he mentioned that he was running a clinical trial that he believed ... what role that organ plays in the process, he said. It will also help ...

Pharm Exec’s 20th Annual Pipeline Report examines the emerging drug development trends and surging investments in five ...

In honor of Rare Disease Day on February 28, 2025, we will publish a series of posts throughout the month on As Prescribed ...

A groundbreaking study led by researchers at Insilico Medicine has revealed the potential of TNIK inhibition as an innovative ...

NVIDIA's continued investment in Recursion Pharmaceuticals strengthens the view that Recursion is a favored investment within ...